Cyteir Therapeutics Inc (CYT) is up Tuesday morning, with the stock increasing 5.28% in pre-market trading to 2.99. CYT's short-term technical score of 72 indicates that the stock has traded more bullishly over the last month than 72% of stocks on the market. In the Biotechnology industry, which ranks 138 out of 146 industries, the stock ranks higher than 88% of stocks. Cyteir Therapeutics Inc has risen 2.90% over the past month, closing at $2.75 on September 5. During this period of time, the stock fell as low as $2.75 and as high as $2.85. CYT has an average analyst recommendation of Sell. The company has an average price target of $2.50.
CYT has an Overall Score of 57. Find out what this means to you and get the rest of the rankings on CYT!